Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. - Bowman C; Dolton M; Ma F; Cheeti S; Kuruvilla D; Sane R; Kassir N; Chen Y (CPT: pharmacometrics & systems pharmacology, 2024)